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high st&piasly sue& rate 0s well as 0 Iti& t&dud mar. 
bidity rate. lteu~~e of this intrtasoll q torbkiby 5(1nte bigk risk 
2tlF emus and arterial cmmula~ inserted and eP&Pulmonary 
bypam iniliwkd. PaGents in lhe rkmdby CR? gmup wereprepar*d 
f0r institution of cardiopulmonary bypass, but bypass was not 
actwily bdtiated unless the patioat sustained irreversibk hrmo- 
dynamic compromise. 
Resulls. There were 389 patients io the prophylxtic CPS group 
and IUO in the standby CPS group. The groups were comparable 
with respect to mosl braiine chsracterirtier, except that ten 
ventricular ejection lraetion WI lawrr in Ule prophylactic CPS 
.qmup. Thirteen of the 180 patient9 in the standby CR gmup 
sustained irreversible hemodynemic romprmnix during the u- 
gbplasty procedure. Emergency tnstltution nf CFS wes sucwss- 
With increased opemtor experience and improved technoi- 
o{:y. the indications fol- percutaneous transiuminal coronary 
altgioplasty have been extended to include some patients ot 
increased procedural risk. Sevenl factors have been associ- 
ated with higb risk coronary angiopiasty inciudingdilatlon of 
lhe left main coronary mkry, poor left ventricular function, 
and dilsliun ofthe only patent curunary artery (1.2). Several 
new devices have been used to support the coronary or 
systemic circulatian, or both. during high risk angioplasry 
procedures. These include autoperfusion catheters (3.4). 
transcatheter infusion of blood substitutes (S), corooary 
Iu!!y initiated in 12 ol these 13 patient5 in C5 mitt. Pmcedurai 
WI:W HBS 88.7% rortke praphytsctie and 84.4% for thestandby 
CPS group (p = h’s). Major complications dld not dtter betweeb 
btoups. Honew, 42% of paths in the prophylncik CPS grm~ 
sWained Rnmral access site compikxthms or required hhwt 
Iranrfusiov,canpated nithoniyl1.7% ofpati0ntt itttitestnndby 
CPS gtwp (p c 0.01). A0WI.g patients witb an eje&tn ItWin 
520%, procedural marbldity remnimd dgnthntty h$hrr lo tke 
praphy,n&c CPS gllJup (41% VP. 9.440, p < 0..1,, but pmrc- 
dmal mortaiityrsshigbn‘io thestandbygrnmp(4.8% ni. I8.8%, 
P =z O.05). 
~rocedorai morbidity was bigber iotbe-pmpby~kgroup. When 
required, standby CPS ertabtt9bed idi& hemwtynamtc sup 
cotm-ry ongio&y. Uow&.-ok& with &m;iy de. 
pressed lot7 wnlritular funetiw (ejectrOn fraelicn <IO%) may 
benefit rom instilntktn of prapbyk~cttc CPS. 
(J Ant Con Cam&~! f933;21590-6) 
sinus retroperfusion (6,7) and pr0phyiactic use of the in- 
traaortic balloon pump (8.9). Recently. the technique of 
partial cardiopulmonary bypass, also known as card~opul- 
monary support ICPS)or “supported angioplasiy,” has been 
developed (10-19). Cardiopulmonary support is accom. 
plished by using a portable, vortex pump-membrane oxygen- 
aor system chat pravides up to 6 ibers!min wrpol with the 
use of I8F or 2UF femoral vein and artery cannulas. After 
several encouraging reports. the National Registry of Blec- 
tjve Cardiopulmonary Support was formed to evaluate the 
initial multicenter results with this procedure. Published data 
from the firsr year of the Registry’s experience (1988) 
documented a high angioplasty success rate (95%) but also a 
r&lively high procedural morbidity tale. particularly with 
respect to femoral access site complications and transfusion 
requirements (20,2i). This increased morbidity led many 
members of the Registry lo place some high risk angiopiasty 
patienfs on so-called “standby CPS” instead of prophylactic 
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CPS. Patients undergoing angioplasty wi& standby CPS 
were prepared for the emergency use of CPS but carchopul- 
monmy bypass was initiated only in the setting of irrevers- 
ible hemodynamic compromise. The objective of this sIudy 
was to compare the procedural outcome of high risk patients 
undergoing angioplasty with standby CPS wilh thaI of pa- 
tients in wham prophylactic CPS was instituted. 
Methods 
Inclusion criteria. The National Registry of Elec:ive Car- 
diopulmonary Support consists of 23 medical centers. Par- 
ticipating centers and the names of the corresponding prin- 
cipal investigators are listed in Appendix A. Registry entry 
criteria for both standby CPS and prophylactic CPS patients 
were as follows. The parient must have I) stable or unstable 
angina pectoris. 2) at least one coronary artrry stenosis 
probably amenable 10 balloon angioplasly, 3) left ventricular 
ejection fraction <25% or an angioplasty target vessel sup- 
piying >SO% of the viable myocardium, or both. In most 
cases in which the indication was angioplasty of a vessel 
supplying X0% of the viable myocardium, the target vessel 
supplied collateral channels to another coronary artery with 
a proximal chronic total occlusion not amenable to balloon 
angioplasty. Patients with acute myocardial infarction were 
excluded from the Registry, as were patients with unstable 
hemodynamic status (systolic blood pressure <!Xl mm Hg) 
before the start of the angioplasty procedure. The assign- 
ment of a particular patient to standby or prophylactic CPS 
was left entirely to the opermor’s discretion. 
Data ealketion. Data forms were completed at the end of 
the hospital stay. Data pertinent to this analysis included 
patient age, gender, angiographic description of coronary 
artery disease, left ventricular ejection fraction (determined 
by contrast or mdionuclide angiography), and performance 
of associated interventional procedures. Standby CPS Pro- 
cedural dataincludedthe presenceorabaence ofsmall (SFor 
6F) sheaths in the contrrdatenrl femoral artery and vein. the 
presence of a “primed” or “unprimed” CPS system on 
standby, the prophylactic use of an inIraaortic balloon 
tmmp, and the need for emergency institution of CPS. 
k&dttral data for patients u&g&g prophylactic CPS 
included method of cannula insertion and method of cannula 
removal, bypass flow and bypass time. Coronary angioplasty 
data included: location of coronary artery Stenoses undergo- 
ing attemp;d dilation sod angiographic appearance of cor- 
onary stenoses after dilation. A successful angioplasty prc~ 
cedure was defined as an intervention resulting in 220% 
decrease in relative diameter vessel narrowing with a resid- 
nal narrowing of ~513% in the absence of major complica- 
tions, including in-hospital death, emergency bypass surgery 
or Q-wave myocardial infarction. The presence of any of the 
following morbid events was also recorded: femoral artery 
pseudoaneurysm, femoral artery occlusion, deep venous 
thrombosis, the presence of a femoral hematoma. retroper- 
itoneal bleed, local infection at the femoral cannulation site, 
femoral nerve weakness and blood transfusion. All data 
forms were submitted to the coordinating center at the 
University of Maryland. 
Prophylactic CPS prwzdure. Prophylactic CPS proce- 
dures were performed in the catheterization IaboraIory un- 
der local anesthesia and mild sedation. Patients were rob- 
tin+ premedicatedwith aspirin, nitroglycerin and aca!cium 
channel blocking agent. Iliac angiography was performed 
before insertion of cannulas to document any iliofemolal 
disease that would preclude the use of large diameter can- 
nulas. Femoral cannulas were inserted either by local CUI- 
down and direct vessel puncrure or by the percutaneous 
insertion technique desci-ibed by Shawt et al. (17). For 
percutaneous insertion, progrc! sive vessel Nmion was un- 
dertaken before cannula insertion. Under Auoroscopic guid- 
ancc. the multiple side-hole 1%: or 10F venous and arterial 
cannulas were uos;:ioned at the iunction of the rieht atrium 
and inferior v=na cava and distal aorta. respectively. Hepa- 
rin was administered in a 300 U/kg dose before insenion of 
cannulas. The activated cIotting time was maintained at 
AOQ s during cardiopdmonaq bypass. Following catmula 
placement, CPS Was instituted to reduce pulmonary capil- 
lary wedge pressure IO ~5 mm Hg and to maintain adequate 
systermc pressure and perfusion during angioplasty ballnon 
int?ation. FLuid administration was commonly required to 
achieve adequate systemic pressure. At?er coronary a~@o. 
PI&Y. CPS was tapered over a period of several minutes. 
Canmda ,.sc\~a! U’S accomplished either by surgical clo- 
SUE or by percutaneously using mechanical groin clamping 
to achieve hemostasis. The heparin etTect was not routinely 
revered with pmtamine after CPS. 
Standby CPS pdure. For standby CPS procedures, 
the CPS equipment and trained personnel were required to 
he present during the angioplasty procedure. Further prep 
aration WBE Left to the operator’s discretion. la most pa- 
tients, iliac angiography was performed IO document the 
iliofemaral anatomy. thereby identifying the most favorable 
iliofemoral artery for poIential CPS insertion. Small, SF or 
6F. sheaths were placed in the contralateral femoral vein and 
anery in 94 (52.2%) patients in the standby CPS group. This 
allowed rapid cannulization under emergency circum- 
stances. In SO (27.F%) patients in de standby CPS group the 
CPS apparatus was fully primed. In II (6.1%). IgF or 2W 
femoral cannulas were inserted but cardiopulmonary bypass 
was not initiated unless urgently needed. Additionaliy, the 
intraaortic balloon pump was inseited prophylactically in 
five patients (2.8%) in the standby CPS group. Heparm was 
administered to patients in the standby CPS group at the 
usual dose given to patients undergoing muline angioplasty. 
This generally is one third to one half of the heparin dose 
given to parients in the pmphylactic CPS group. When 
emergency cannulation was required, it was performed by 
the percutaneous insertion technique described above. Once 
cannutas were inserted, cardiopulmonary bypass nas insti- 
tuted as in patients in the prophylactic CPS group. 
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Table 1. Baseline Chamcte:islics of 569 Patients With 
Prophylactic or Strndoy Cardiopulmonary Support 
Age 275 yean 
Female 
Lesions dilated per 
pnieot Ino.) 
Unprotecred Iefl main 
dilated 
Only patent vessel 
dilated 
LVEF (mean) 
LVEF Go% 
Prophylactic CPS Standby CPS 
(n = 389) I” = IBO) p value 
54(13.9) 12 (17.8) NS 
88 (22.6) 56(31.11 NS 
I .?5 l.hS NS 
36 19.3) IO (5.6) NS 
II9 130.6) 3? (20.6) NS 
27.5% 36.7% < 0.01 
126 132.4) 32 (17.8) < 0.05 
CPS = cardiopulmonary rupporl; LVEF = IcR venlricular ejeclion 
fraction. Unless olhenulle indrtated. data are expressed as number (%) of 
S!alistiLs. Comparisons were made by using the Student 
I test for continuous variables and the chi-square or Fisher 
exac! test for categoric variables. 
RC?SltltS 
Baseline characteristics of our study patients are listed in 
Table I. From 1989 through 1990 there were 389 patients in 
the prophylactic CPS group and 180 in the standby CPS 
group. The two groups did not differ with respect to age, 
gender, number of lesions dilated/patient, or dilation of 
unprotected left main coronary artery stenoses. More Pa- 
tients in the prophylactic CPS group underwent dilation of 
the only patent vessel (30.6% vs. 20.6%) but this difference 
was not significant. The mean left ventricular ejection frac- 
tion was significantly lower in the prophylactic CPS group 
(27.5% vs. 36.7%, p < 0.01). Additionally, the prophylactic 
group contained more patients with an ejection fraction 
520% (32.4% vs. 17.8%, p c 0.0s). Thus, the two groups 
were not entirely comparable with respect to this important 
baseline characteristic. 
The procedural outcome is displayed in Table 2. Proce- 
dural success for the two groups was similar, 88.7% for 
patients in the prophylactic group and 84.4% for those in the 
Table 2. Procedural Outcome in Total Patient Group 
I’mphyla& CPS Standby CPS 
Procedural IUECCSS 
In = 3891 (II = iso, p Value 
345 (88.7) IS2 184.4) NS 
Major complications 
Q wave MI 2 (0.5, I III NS 
Emergency CABG II ,I81 4 (2.21 NS 
Death 25 (6.41 II (6.1) NS 
Morbidity 
Femoral complications or 163 (41.91 21 (Il.71 c 0.01 
transfusion requirement 
p-p 
CABG = cornnary bypass surgery; MI = myowd~al infxction; other 
abbreviation as in Table I. Data are cxpreard as number (~6) or patients. 
Table 3. Morbidity in Total Patient Gmup 
Raphylactic CPS Standby CPS 
,n = 389) 0l= ,801 0 Value 
3 I 
IO 0 
I I 
3 0 
21 5 
2 2 
5 0 
3 0 
I 0 
49cl2.61 II 16.1) 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
NS 
< 0.05 
standby CPS group (p = NS). Major complications were also 
similar. The mortality rate was 6.4% for the prophylactic 
group and 6.1% for the standby group (p = NS). This high 
mortality rate is consistent with the high risk nature of the 
patients in this study. Emergency bypass surgery was re- 
quired in 2.8% of prophylactic versus 2.2% of standby CPS 
groups (p = NS). There was a major difference in procedural 
morbidity between the two study groups. Forty-two percent 
of patients in the prophylactic CPS arouo sustained femoral 
complications or required blood transfusions compared with 
only 11.7% of patients in the standby CPS group (p < 0.01). 
Thus, although procedural success and major complication 
rates did not differ, overall morbidity was significantly 
increased in the prophylactic CPS group. 
Procedural morbidity is analyzed further in Table 3. 
Femoral complications such as pseudoaneurysm, femoral 
artery occlusion, deep venous thrombosis, hematoma, ret- 
roperitoneal bleeding, arteriovenous fistula, femoral itiec- 
tion or femoral nerve weakness were all more frequent in the 
prophylactic than in the standby CPS group. Transfusion 
requirements were strikingly different between the two 
groups. Blood transfusions were required in 39.1% of pa- 
tients in the prophylactic CPS group hut in only II .4% of 
those in the standby CPS group (p < 0.01). 
Emergenq hwtitulion d CPS ia patients with statiby 
CPS. Thirteen (7.2%) of the 180 patients in the standby CPS 
group sustained irreversible hemodynamic compromise dur- 
ing the angioplasty procedure and required emergency insri- 
tution of CPS. Bypass was successfully initiated in 12 of the 
13 patients within 5 min. One patient required IO min for 
initiation of bypass and sustained irreversible brain dcage, 
resulting in death. The indications for emergency CPS in 
standby patients were as follows: abrupt closure of the 
vessel treated with angioplasty occm+ed in two patients, 
catheter dissection of the IeA main coronary artery in one 
patient and irreversible bypotension after coronary instm- 
mentation or balloon inflations, or both, occurred in 10 
patients. 
Registry entry criteria for the 13 patients requiring emer- 
EMERGENCYCPSREQUIRED(13) 
& 1 
+ + f 4 
Discharged Late, Discharge.3 Po*-operati”e 
wk. fw?her in-hospital w/o further da& (21 
complications death (2) complications 
(6) (2) 
Figure I. Outcome after emergency insliturion ‘II cardiopulmonary 
support (CPS) in pa&Is in the standby CPS group. EM-CA& = 
emergency coronary artery bypass surgery; V&J = without. 
gency institution of CPS were as follows: 7 had >50% of 
their viable myocardium jeopardized by the target angio- 
plasty vessel, 2 had angioplasty of the only patent vessel: 4 
patients had a left ventricular ejection faction <25%. 
The outcome of the 13 patients in the CPS group standby 
requiring emergency CPS is displayed in Figure I. One 
patient requiring 10 min for inhiation of CPS died as de- 
scribed earlier. In eight patients the procedure was SUCCFSS- 
fulbi completed without requiring emergency bypass SUP 
gery. Six of these eight patients were discharged from the 
hospital without further complications and two patients died. 
one because of abrupt vessel closure 2 days after the 
procedure and one because of congestive heart failure a1 1 
week. In four patients in the standby CPS group, emergency 
bypass surgery was performed after institution of CPS. Two 
of these four oatients had a successful outcome and two died 
wstoLwalivelv. _-- r---~- ~_ 
Hasplta~ mortality. The hiih procedural mortality in this 
study underscores the high risk nature of the patients under- 
going revascularization. The events surrounding each pa- 
tient’s death are listed in TabIe 4. There were 36 deaths. 
Tat& 4. Mowliry in Toral Patient Group 
Pmphylac,~ CPS Standby CPS 
,n = 3891 ,a = 180) 
Death during auic@asty 2 I 
Death utIeremerse”cy CABG for failed 5 z 
angiopbty 
Rophylaclk Stmdby 
CPS CPS 
al = 126, ,n = 3-0 r’ Value 
Only IO (27.8%) of the 36 occurred as an immediate compli- 
cation of the angioplasty procedure (either death in the 
cathererization laboratory or death after emergency bypass 
stirgery). The remaining 26 deaths (72.2%) occurred later in 
the hospitalization after an initially successful angioplasty 
procedure. Fourteen of these deaths were due to cardiac 
arrest. probably caused by late closure of the recently 
dilated vessel. Twelve deaths were due to aspiration pneu- 
monia. hemorrhage. congestive heart failure or sepsis. 
Patients with an ejeetinn fraclion 520%. More patients in 
the prophylactic CPS group had severely reduced left ven- 
tricular function. Therefore, Ihe outcome of patients with a 
left ventricular ejection fraction 520% in the prophylactic 
and standby CPS groups was compared (Table 51. There 
were I58 oatients in this.subeFouu. 126from the orodv[actic 
and 32 from tbe standby CP: subgroup. P~ocedirai morbid- 
ity was significantly higher in the prophylactic CPS group 
(41% vs. 9.4%. p < 0.01). but procedural mortality was 
higher in the stamtby group (4.8% vs. 18.8%, p < 0.051. 
Discussion 
Femoral vein to artery cardiopulmonary bypass has been 
used to provide hemodynatttic support in diverse clinical 
settings. After its initial use in cardiac surgery (10.13,19), 
this technique has recently been applied outside the operat- 
ing room to patients undergoing percutaneous aortic valvu- 
loplasty or e!ective but high risk coronary angiopiasty, 
patients with in-hospital cardiac arrest and patients in EV- 
diogenic shock due to acute myocardial infarction (15,18,22). 
The technology of CPS differs from that of traditional 
cardiopulmonary bypass systems in that a centrifugal pump 
is used to aspirate blood from the central venous pool 
instead of a gravity-fill system. Systemic flow rates of 4 to 6 
literslmin can be obtained by using 18F to 20F cannulas. 
These large diameter cannulas can be inserted percutane- 
ously by using the sequential dilating techniqii;: af S!iaxl et 
al. (17.23). In 1988 the National Registry of Elective Cardio- 
pulmonary Support was established to evaluate the initial 
experience with this technology (20,Zl). In the first 
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year of the Registry’s experience, 14 centers enrolled 105 
high risk angioplasty patients with use of the inchtsion 
criteria described in this study. Although the angiaplasty 
success rate was high (95%). complications were frequent. 
The in-hospital mortality rate was 7.6% and was particularly 
high in patients >75 years old with left main coronary artery 
disease. Overall, 39% of patients experienced complications. 
Most complications were related to the femoral cannulation 
site and 43% of patients required blood transfusion. 
Present study. With increased experience, Registry mem- 
bers found the time required for percutaneous insertion of 
cannulas and initiation of cardioy..:!mmtary bypass de- 
creased to <5 min. uarticttlarlv if femoral access was arevi- 
ously obtained with’small diameter sheaths. In light bf the 
complications associated with CPS, it seemed reasonable to 
place sume hiih risk angioplasty patients on “standby CPS” 
(24). The level of standby readiness varied among institu- 
tions. In general, the physician matched his or her skill at 
urgently initiating CPS with the level of Patient risk. Maw 
patie& (52.2%)had instrumentation oi the contralateral 
femoral access site, and some patients (27.8%) had the CPS 
apparatus primed. Priming the CPS apparatus incurs a cost 
ofapproximarely $l,ooO. Therefore, most physicians primed 
the system only for those patients whose condition was 
considered most tenuous. 
Patient selection for standby CPS versus prophylactic 
CPS also varied among institutions. Generally, as physician 
experience with standby CPS increased, more patients were 
treated wifh this technique. Patients in the standby and 
prophylactic CPS groups were similar with respct to most 
baseline clinical and anatomic factors except that left vett- 
tricular function was worse in the prophylactic CPS group 
(see Study iimitations section). This difference reflected the 
feeling of many operators that the highest risk patients 
should be Dlaced on CPS DmDhvlacticallv. Therefore. be- 
cause of these patient selectibtt- differences, standby’ and 
prophylactic CPS patients were not at precisely equivalent 
risk. However, the requirement for emergency institution of 
CPS in 13 patients (7.2%) in the standby CPS group is 
evidence that the standby group clearly represented a high 
risk group. 
In this study, standby CPS provided excellent support for 
most high risk angioplasty patients. Patients in the prophy- 
lactic and standby CPS groups had similar success and major 
complication rates. However, those in the prophylactic CPS 
group had more femoral access site complications and a very 
significant increase in blood transfusion reauirement (39.1% 
vs. 11.4%, p < 0.01). Therefore, for the study group as a 
whole, prophylactic initiation of CPS resulted in increased 
morbidity and no improvement in outcome compared with 
that of standby CPS. 
Review of the study data suggests several explanations 
for the lack of benefit from prophylactic CPS. 1) The success 
rate in the standby CPS 8roup was hiih (84.4%) and similar 
10 that reported in the National Heart, Lung, and Blood 
Institute and several other large angioplasty series (2.5-28). 
Thus, standby CPS is a highly effective technique pmviding 
results in high risk angioplasty patients simi!ar to those 
reported for more routine angioplasty patients. It would he 
difficult for prophylactic CPS 10 improve on this high success 
rate. 2) The results of this study demonstrate that standby 
CPS can reliably establish immediate hemodynamic support 
for patients experiencing angioplasty complications. The 
immediate availability of CPS in the standby group clearly 
improved the angioplasty success rate and decreased com- 
plications. Thirteen of the 180 patients in the standby CPS 
group had irreversible hemodynamic deterioration during 
angioplasty. In I2 of the 13 patients, CPS was successfully 
initiated and 6 of the I2 went on tc have a successful 
procedure without requiring bypass surgery. Of the four 
patients in the standby CPS group taken to emergency 
bypass surgery, two survived and two died. Thus, the 
availability of CPS almost certainly prevented eight deaths in 
the standby CPS group. Therefore, without CFS the mortal- 
ity rate in the standby group would probably have been 
10.6%, underscoring the effectiveness of the standby tech- 
nique. 3) Our standby and prophylactic CPS groups had 
similar outcomes because the majority of deaths occurred 
after the angioplasty procedure when prophylactic CPS 
could no longer benefit the patient. Fully 72.2% of the study 
deaths occurred late in the hospital stay after an initially 
successful procedure. Most of the deaths were probably due 
to closure of the angioplasty target vessel: the remaining 
deaths were due to multiple medical complications. Obvi- 
ously, prophylactic CPS can provide hemudynamic support 
only during the procedure and cannot reduce complications 
occurring outside of the catheterization laboratory. 
In a subgroup analysis (Table 5), patients with a left 
ventricular ejection fraction 52G% reeeivinp: urouhvlactic 
CPS had a si&ficantly lower procedural moGtyir& than 
that of patients in the standby group. Thus, this subgroup 
with extremely depressed left ventricular function appears to 
be at highest risk. Prophylactic institution of SPS may be 
indicated in this subgroup. 
Requirement for CPS institution ht patients in the standby 
CPS group. Only 13 of the I80 patients in the standby CPS 
group required emergency institution of cardiopulmonary 
bypass. This small number precludes rigorous analysis of 
factors in the standby group predictive of the need for CPS 
institution. The majority of these patients did ttof have an 
ejection fraction ~25%. Thus, at present it should be em- 
phasized that the need for CPS institution in patients in the 
standby group is unpredictable, ana all patients meeting our 
entry criteria should be considered potential candidates for 
its emergency use. However, only 2.8% of patients in the 
standby group had prophylactic insertion of an inhaaortic 
balloon pump and only 1 of the 13 patients in the standby 
group requiring CPS institution had prophylactic balloon 
pump insertion. In a recent report (29). pmphylactic inser- 
tion of an intraaortic balloon pump was used successfully as 
a support mechanism for patients with poor left ventricular 
function undergoing coronary angioplasty. It is possible that 
initiation ofCPS would have been required less frequently if 
more patients in our standby CPS group had hecn supported 
prophylactically with an intraaurtic balloon pump. 
Study Bmitations. There are several limitations to th.s 
study. Patients were not randomized and more patients in 
the prophylactic than in the standby CPS group had severely 
depressed left ventricular function. When a subgroup of 
patiems with an ejection fraction a20’3 was compwed 
(Table 5) there was a mortality benefit for patients in the 
prophylactic CPS group. However. the number of patientr in 
this subgroup was small, possibly resulting in statistical 
artifact or inadequate baseline comparability of the two 
groups (30). Additionally, because most deaths in this study 
occurred well after the angioplasty procedure and. when 
needed, CPS could be quickly initiated in almost all patients. 
one cannot conclude that prophylactic initiation of CPS 
would have reduced mortality in this subgroup. 
Very few patients in the standby g.roup in this study 
underwent prophylactic support with an intraaortic balloon 
pump. If patients in this group had been routinely supported 
with the intraaortic balloon pump, the need to institute CPS 
might have been reduced. In particular. the very high 
mortality rate for patients in the standby group with an 
ejection fraction 520% might have been favorably influ- 
enced by prophylactic balloon tntmo insertion. 
Clhtieai im&&iens. The most clinically significant find- 
ing of this study was that standby CPS provided effec!ive 
support tn tile setting of sudden, otherwise irreversible. 
hemodynamic ?etziora:iou in all but one patient in the 
standby group. The similar success and ntajor complication 
rates for patienls in the prophylactic and standby CPS 
groups were due to the ability of CPS to stabilire the 
condition of I2 of the 13 patients in the standby gmup who 
required immediate hemcdynamic support. Eight of these 
patients ultimately survived. Without the immediate avail- 
ability of CR, these patients would probably have died. The 
standby technique was superior to the prophylactic iech- 
niquc iit the majority of our study group because CPS was 
directed only to those relatively few patients wh:, definitely 
required it. Most patients were spared the morbidity of 
femoral cannulation and cardiooulmonarv bvwss. In addi- 
tion, patients in the standby CPS group ~ereOusually spared 
the significant cost (approximately $l.oaO) of the equipment 
required for femoral cattnulation. This savings. added to 
savings fmm reduced morbidity (less transfusion, femoral 
artery injury, and so forth) ttndctswrrs important economic 
advantages of standby CPS. 
As the CPS procedure evolves, morbidity, particularly 
blood transfusion requirements, will likely decrease. How- 
ever, no benefit was derived from prophylactic CPS in our 
patients with an ejection fraction >ZO%. Even if morbidity 
rates were as low as those of stattdbf CPS. the increase in 
procedure time, patient discomfort and expense would pro- 
hibit use of prophylactic CPS unless a ctear benefit is 
demonstrated. 
A subgroup of patients with an ejection fraction 90% 
demonstrated improved survival with prophylactic CPS. 
Thus. this technique may be indicated in patients with 
e~tr~rn~ left ventricular dysfunction. This subgroup war- 
rants further study, ideally a randomized trial using intraaor- 
tic balloon support for patients in the standby CPS arm. 
lnilialion of CPS is a relatively complex procedure requir- 
ing spccdic technical skills and a high degree of coordination 
among physicians. nurses, cardiovaacutar technologists and 
perfunionists in the catheterization laboratory. To urgently 
initiate CPS in a pathnt in the standby CPS group. it is 
essential that the patient be well prepared (preferably the 
contralateral femoral vessels instrumented and the iliofemo- 
ral anatom) defined) and the catheterization laboratory team 
well practiced in the technique. Before a cardiac center uses 
&;mdby CPS. experience with prophylactic CPS is manda- 
rory. Furthermore, the catheterization laboratory policy and 
procedures must require periodic dry run-tkmughs to main- 
tain proficiency. 
Ftaallv. the high fteauencv of late mottatitv in this studv 
desel,ves-special;mpbsis. Most deaths (7212%) occurred 
outside of the catheterization laboratory when CPS was not 
immsdiately available. Mortality was due either toclosure of 
an angioplasty target vessel or associated medical problems. 
This finding underscorer the fact that patients requiring 
prophylactic or standby CPS are often relatively ill and 
tolerne late complications poorly. Vigilant and meticulous 
medical care is essential after the angioplasty procedure. 
Furthermore, the overall high mortality rate in this study 
underscores the imoortance of case selection. The relalive 
risks and benefits of coronary bypass surgery versus an& 
plasty using either CPS or standby CPS must be carefully 
considered. 
Conclusions. In this study, standby CFS provided excel- 
lent support for patients undergoing high risk angioplasty 
procedures. The CPS was urgently required in 7.2% of 
standby patients. When needed. standby CPS reliably estab 
lished immediate hemodynamic support in almost all pa- 
tients. Patients in the standby and pmphylactic CPS groups 
had comparable stteeess and major complication rates but 
procedural morbidity was more frequent in patients in the 
prophylactic CPS group. For most patients studied here, 
standby CPS was preferable to prophylactic CPS during high 
risk coronary angioplasty. However. patients with ex- 
tremely depressed left ventricular function (ejection fraction 
<20%) may benefit from jnstitution of prophylactic CPS. 
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